Featured News

$_EscapeTool.xml(${alt})

COVID long-haulers face stigma as well as lingering symptoms, study shows

  • 16 January 2023
$_EscapeTool.xml(${alt})

Albertans urged to protect themselves as highly transmissible XBB.1.5 subvariant shows signs of growth

  • 12 January 2023
$_EscapeTool.xml(${alt})

B.C. sea sponge has COVID-blocking powers

  • 09 January 2023

Recent Posts

2023-01-18-long-covid.jpeg

COVID long-haulers face stigma as well as lingering symptoms, study shows

  • 16 January 2023
2023-01-12-sars-cov-2.jpg

Albertans urged to protect themselves as highly transmissible XBB.1.5 subvariant shows signs of growth

  • 12 January 2023
2023-01-09-bc-sea-sponge.jpg

B.C. sea sponge has COVID-blocking powers

  • 09 January 2023
2021-support-virus.jpg

XBB.1.5 is the latest COVID-19 subvariant: What you need to know

  • 09 January 2023
2023-01-06-albertans-rate.webp

At least 2,095 Albertans died of COVID in 2022, roughly matching the death toll from 2021

  • 06 January 2023
2022-12-27-covid-new-entry.jpg

Researchers identify insidious new way COVID-19 virus uses to invade cells

  • 27 December 2022
2022-12-14-mona-nemer-long-covid.webp

Canada's chief science adviser releases recommendations to combat long-COVID

  • 14 December 2022
2022-12-09-pfizer-biontech-bivariant.jpg

Health Canada approves first bivalent booster for kids ages 5 to 11

  • 09 December 2022
2022-06-06-monkeypox.jpg

LKSIoV Member David Evans explains how new viruses get their names and why they sometimes change

  • 02 December 2022
2022-11-23-prairies-highest-flu-rates.png

Prairies see highest rates of positive flu tests in Canada

  • 23 November 2022
2022-11-16-kids-rsv.jpg

Kids are getting hit hard by respiratory viruses

  • 16 November 2022
2022-10-03-cancer-shutterstock_181677413.jpg

Health Canada has approved AstraZeneca’s antibody combination Evusheld as a treatment for COVID-19

  • 19 October 2022
2022-10-03-sore-throat-covid.webp

Influenza, COVID-19 vaccines important to prevent 'twindemic'

  • 17 October 2022
2022-10-05-pfizer-bivariant.jpg

Health Canada approves Pfizer’s bivalent booster, targeting Omicron subvariants, for Canadians ages 12 and older

  • 05 October 2022
2022-10-03-sore-throat-covid.webp

Sore throat is in, fever and loss of smell out when it comes to current symptoms of COVID

  • 03 October 2022
2022-10-03-cancer-shutterstock_181677413.jpg

Study shows cancer patients may be at greater risk of death from COVID-19

  • 03 October 2022
2022-09-09-pfizer-biontech-kids-under-5.jpg

Health Canada approves Pfizer-BioNTech COVID-19 vaccine for kids under 5

  • 09 September 2022
2021-11-22-news-nasal-spray.jpg

US scientists join forces to study leading theory behind long COVID

  • 08 September 2022
2022-09-01-moderna-vaccine.jpg

Health Canada approves first COVID-19 vaccine variant specifically targeting Omicron

  • 01 September 2022
2022-08-19-kids-booster.jpg

Health Canada approves 1st COVID-19 booster for kids 5-11

  • 19 August 2022
2022-08-11-pregnant-study.jpg

Canadian study confirms that pregnant women who received mRNA COVID-19 vaccines aren’t more at risk of miscarriage or stillbirth

  • 11 August 2022
2022-08-02-ab-vaccine-under-5.jpg

Alberta now vaccinating children under 5 against COVID-19

  • 02 August 2022
2022-07-28-imvamune.png

Alberta expands monkeypox vaccine eligibility

  • 28 July 2022
2022-07-20-4th-dose.png

Fourth doses now available in Alberta

  • 20 July 2022
2022-07-14-vaccine-under-5.jpg

Health Canada approves first COVID-19 vaccine for kids under 5

  • 14 July 2022
2022-06-23-long-covid.jpg

Experts explore long COVID treatments as thousands of Albertans seek relief

  • 22 June 2022
2022-06-09-ab-rates.jpg

Alberta hit by far more COVID deaths this year than in the same period in previous years

  • 09 June 2022
2022-06-04-evusheld.jpg

Antibody therapy, Evusheld, available for some immunocompromised Albertans to prevent COVID-19 infections

  • 04 June 2022
2021-12-13-news-sixth-wave.jpg

Sixth Wave AMIPS(TM) technology 250 times more sensitive than commercial rapid antigen tests in COVID virus detection with no cross-reactivity

  • 24 May 2022
2022-05-03-long-covid.jpg

Long COVID impacts continue as Alberta doctors and researchers seek answers

  • 03 May 2022
2022-04-25-unvax-risk-vaxxed.jpg

Canadian study shows unvaccinated people can increase risk of COVID-19 infection among vaccinated

  • 25 April 2022
2022-04-21-who-backs-paxlovid.webp

WHO supports Pfizer's oral COVID therapy, Paxlovid, for high-risk patients

  • 21 April 2022
2022-04-12-folio-evans-device1100.jpg

LKSIoV member David Evans and his team supported TESER Technologies in the development of a sanitizing device to kill SARS-CoV-2 in 60 seconds

  • 12 April 2022
2022-04-13-6th-wave-booster.jpg

NACI recommends a booster shot for those aged 12 and up

  • 12 April 2022
2022-04-05-2nd-booster.jpg

Canada's vaccine advisory body recommends 4th dose for those 80+ years

  • 05 April 2022
2022-03-17-moderna-kids.jpg

Health Canada approves Moderna COVID-19 vaccine for kids aged 6 to 11

  • 17 March 2022
2022-03-01-nerve-damage.jpg

A US study finds that nerve damage may explain some cases of long COVID

  • 01 March 2022
2022-02-24-medicago-greenhouse.jpg

Health Canada has approved Medicago's plant-based COVID-19 vaccine

  • 24 February 2022
2022-02-17-novavax.jpg

Novavax’s protein-based COVID-19 vaccine gets approval for use in Canada

  • 17 February 2022
2022-02-09-moderna-hiv.jpg

Moderna's mRNA technology paves way for HIV vaccine

  • 09 February 2022
jama.jpg

Study shows 57% of babies of mRNA-vaccinated moms have antibodies at 6 months

  • 07 February 2022
2022-02-07-childbirth-risks.jpg

Moderate COVID tied to higher childbirth risks

  • 07 February 2022
2022-02-04-booster-after-covid.jpg

Canada’s National Advisory Committee on Immunization (NACI) recommend vaccinated Canadians who catch COVID-19 can get booster 3 months after positive test

  • 04 February 2022
2022-02-03-novavax-in-new-zealand.jpg

Canada’s Novavax COVID-19 vaccine receives provisional approval in New Zealand

  • 03 February 2022
2022-02-02-omicron-variant.jpg

WHO reports that omicron sub-variant detected in 57 countries

  • 02 February 2022
2022-02-02-challenge-study.jpg

Britain’s COVID-19 human challenge trial offers insights into why the virus spreads so quickly

  • 02 February 2022
2022-01-26-moderna-omicron-trial.jpg

Moderna begins clinical trial for omicron-specific COVID-19 booster shot

  • 26 January 2022
2022-01-25-pfizer-3-shots-kids.jpg

NACI recommends immunocompromised children 5-11 yrs old should be offered 3 doses of the Pfizer COVID-19 vaccine

  • 25 January 2022
2022-01-25-pfizer-omicron-trial.jpg

Pfizer-BioNTech begin clinical trial for Omicron-targeted COVID-19 vaccine

  • 25 January 2022
2021-12-13-news-sixth-wave.jpg

Sixth Wave AMIPs(TM) technology provides opportunity for less invasive, less expensive testing

  • 25 January 2022